MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    A corneal nerve density possible progression biomarker in Parkinson’s disease (PD) patients: pilot study

    S. Yaisawang, J. Sringean, N. Kasetsuwan, R. Bhiyasiri (Bangkok, Thailand)

    Objective: To evaluate corneal sub-basal nerve plexus density in PD compared to age-matched healthy subjects using confocal microscopy Background: Cornea is the most densely innervated…
  • MDS Virtual Congress 2021

    Hearing Impairment was not associated with Dream Enactment Behavior and Parkinsonism in the Population: a CLSA Prospective Study

    C. Yao, A. Szpindel, A. Pelletier, R. Postuma (Montréal, Canada)

    Objective: To assess the associations of hearing function with the progression of parkinsonism in a population-based prospective study. Background: Hearing impairment is a common symptom…
  • MDS Virtual Congress 2021

    Using smartphone data to infer social behaviour in Parkinson’s: proof of principle and the impact of COVID19

    H. Zhang, E. Poliakoff, B. Parsia, S. Harper (Manchester, United Kingdom)

    Objective: To investigate the potential of using smartphone data to infer changes in social behaviour in people with Parkinson's and how this has been impacted…
  • MDS Virtual Congress 2021

    Reducing anxiety improves freezing of gait in Parkinson’s disease patients

    A. Al Jaja, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)

    Objective: Investigate the effect of reducing anxiety using a known anxiolytic, alprazolam, on FOG symptoms severity and frequency. This reduction, in turn, might reduce the…
  • MDS Virtual Congress 2021

    Role of S100B in the Pathogenesis of Parkinson’s Disease

    V. Balendra (Park Ridge, USA)

    Objective: This review aims to analyze studies on the implication of S100B in Parkinson's Disease (PD) and shed light on Pentamidine as a novel treatment in…
  • MDS Virtual Congress 2021

    MICROBIAL TRANSLOCATION IN PATIENTS WITH PARKINSON DISEASE AT THE UNIVERSITY TEACHING HOSPITAL, LUSAKA, ZAMBIA: A CASE CONTROL STUDY

    L. Chishimba, E. Sinkala, P. Kelly, M. Atadzhanov (Lusaka, Zambia)

    Objective: To study the association of microbial translocation in patients with Parkinson disease in Zambia. Background: Over the past few years evidence has emerged that…
  • MDS Virtual Congress 2021

    Sphingosine-1-phosphate, motor severity and progression in Parkinson’s disease (MARK-PD)

    C. Choe, C. Englisch, L. Niemann, S. Lezius, M. von Lucadou, K. Marmann, R. Böger, S. Peine, G. Daum, C. Gerloff, E. Schwedhelm (Hamburg, Germany)

    Objective: We assessed the association of serum sphingosine-1-phosphate (S1P) levels with motor and cognitive symptoms in patients with Parkinson’s disease (PD). Background: Treatment with sphingosine-1-phosphate…
  • MDS Virtual Congress 2021

    GBA Mutation Accumulates Higher Alpha-Synuclein in Alpha-Synucleinopathies

    T. Eid (London, United Kingdom)

    Objective: To investigate whether post-translational modifications of α-synuclein will give rise to species that differ between PD cases with N370S GBA mutation and WT-PD. Background:…
  • MDS Virtual Congress 2021

    Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.

    H. Gonzalez-Usigli, A. Gonzalez-Vazquez, J. Garcia-Rivera, O. Padila-Delatorre, A. Leon-Gil, H. Gonzalez-Rodriguez (Guadalajara, Mexico)

    Objective: To find any relationship between cardiovascular risk factors such as diabetes mellitus, hypertension or both and worse state in patient with PD measured with…
  • MDS Virtual Congress 2021

    Does the observation of an action inserted in an emotion-enriched context influence cortical excitability in patients with Parkinson’s disease?

    G. Lagravinese, E. Pelosin, A. Bisio, G. Bonassi, M. Putzolu, A. Botta, C. Cosentino, C. Ponte, S. Mezzarobba, L. Avanzino (Genoa, Italy)

    Objective: To explore the effect induced by the observation of a grasping movement, inserted in different emotional contexts, on cortico-spinal excitability, in healthy people and…
  • « Previous Page
  • 1
  • …
  • 794
  • 795
  • 796
  • 797
  • 798
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley